ClinicalTrials.Veeva

Menu

HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking (HYPERWALK)

Karolinska Institute logo

Karolinska Institute

Status

Enrolling

Conditions

Hypertension
Obesity and Overweight
Cardiovascular Diseases
Metabolic Disease

Treatments

Behavioral: Stair and brisk walking combined
Behavioral: Standard care
Behavioral: Brisk walking

Study type

Interventional

Funder types

Other

Identifiers

NCT06952348
2024-05912-01

Details and patient eligibility

About

This clinical trial investigates whether incorporating stair walking into daily routines improves physical health in adults at risk of lifestyle-related conditions such as hypertension, type 2 diabetes, and cardiovascular disease. Participants will be randomized into three groups: (1) stair walking combined with brisk walking, (2) brisk walking alone, and (3) a control group receiving standard lifestyle advice without specific exercise instructions, stratified by age (<65 y/o, v >=65) and site.

The primary objective is to assess whether the combination of stair and brisk walking leads to greater reductions in systolic blood pressure compared to brisk walking alone or standard care. Secondary outcomes include changes in cardiometabolic risk factors.

Participants in the stair walking group will be instructed to climb ≥250 steps per day (~5.5 minutes/day or ~37.5 minutes/week), or complete an equivalent elevation via inclined slopes, along with ≥75 minutes of brisk walking per week. Those in the brisk walking group will walk ≥150 minutes per week. The control group will receive general lifestyle advice but no tailored physical activity goals or feedback.

Participants in both active groups will aim to double their baseline activity levels. Physical activity will be continuously monitored using wearable devices. The active groups will receive personalized feedback and motivational support throughout the 6-month intervention period.

If effective, this study may offer a simple, scalable, and low-cost intervention model for use in clinical and public health settings, emphasizing personalized goals, remote monitoring, and behavioral support.

Enrollment

450 estimated patients

Sex

All

Ages

35+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Men and women aged 35 years or older with increased cardiometabolic risk, defined by all of the following:

  1. Clinically confirmed hypertension, with or without antihypertensive treatment, as documented in the Electronic Health Record (EHR).

  2. Overweight or obesity, defined as BMI between 27 and 40.

  3. Physically inactive lifestyle, defined as either:

    • Light intensity or inactive category on the Stanford Brief Activity Survey (SBAS), or
    • Light intensity or inactive category in the physical activity section of the Swedish National Board of Health and Welfare Lifestyle Questionnaire.

Exclusion Criteria

Medical contraindications to physical activity (based on FYSS 2021, p. 182):

  • Severe, symptomatic aortic stenosis
  • Acute pulmonary embolism, myocarditis, pericarditis, or systemic infection (e.g., fever, muscle pain, lymphadenopathy)
  • Suspected or known aortic dissection
  • Severe hypertension (Grade 3: SBP >180 mmHg or DBP >110 mmHg), regardless of symptoms
  • Unstable coronary artery disease (including unstable angina, suboptimally treated stable angina, or recent myocardial infarction <8 weeks)
  • Symptomatic, uncontrolled arrhythmia
  • Symptomatic, uncontrolled heart failure

Other exclusion criteria:

  • Implanted pacemaker or ICD
  • Pregnancy
  • Smartphone incompatibility with Fitrockr© app (iOS <16 or Android OS <10)
  • Inability to understand Swedish or English
  • Any condition that may interfere with protocol compliance (e.g., severe mental illness or cognitive impairment)
  • Inability to walk stairs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

450 participants in 3 patient groups

Stair and brisk walking combined
Experimental group
Description:
Participants will double their baseline physical activity levels by combining stair walking and brisk walking. The stair walking goal is ≥250 steps per day (equivalent to \~37.5-45 meters elevation or 15 floor levels), totaling \~37.5 minutes per week. In addition, they will complete ≥75 minutes of brisk walking per week.
Treatment:
Behavioral: Stair and brisk walking combined
Brisk walking
Experimental group
Description:
Participants will double their baseline physical activity levels by engaging in brisk walking only, with a minimum target of \>150 minutes per week.
Treatment:
Behavioral: Brisk walking
Standard care
Active Comparator group
Description:
Participants will receive general lifestyle advice aligned with current physical activity guidelines but will not be provided with specific exercise instructions, personalized activity targets, or feedback. They will wear the same activity monitor as the intervention groups, but without access to feedback or goal-setting features.
Treatment:
Behavioral: Standard care

Trial documents
1

Trial contacts and locations

4

Loading...

Central trial contact

Carl Johan Sundberg

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems